- August 29, 2022
- Newsletter
- 617-430-5616
Menu
ADVERTISEMENT
ADVERTISEMENT
Background
Epidemiology
Anatomy
Pathophysiology
Etiology
Genetics
Prognostic Factors
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Mild/moderate/severe:
875
mg
every 12 hrs or 500mg every 8hrs
In the case of mild/moderate infections: 500 mg orally every 12 hours or 400 mg intravenously every 12 hours for 7-14 days
In the case of severe/complicated infections: 750 mg orally every 12 hours or 400 mg intravenously every 8 hours for 7-14 days
Limitations for usage: Reserve the fluoroquinolones for patients who are voided of available treatment options for chronic bronchitis
Indicated for Chronic Asthma
For no earlier record of the inhaled corticosteroid usage: 40-80 mcg of beclomethasone inhaled orally two times a day as an initial dose may enhance the dose as necessary. It should not surpass 320 mcg two times a day
For an earlier record of the inhaled corticosteroid usage: 40-160 mcg of beclomethasone inhaled orally two times a day depending on earlier dose and disease severity. It should not surpass 320 mcg two times a day
Mild/moderate/severe :
45 mg/kg daily divided in doses for every 12hrs or 40 mg/kg per day in divided doses for every 8hrs
Indicated for Chronic Asthma
Age >12 years
For no earlier record of the inhaled corticosteroid usage: 40-80 mcg of beclomethasone inhaled orally two times a day; may enhance the dose for desired response following more than two weeks of treatment. It should not surpass 320 mcg two times a day
For earlier records of the inhaled corticosteroid usage: 40-160 mcg of beclomethasone inhaled orally two times a day depending on earlier dose and disease severity; may enhance the dose for desired response following more than two weeks of treatment. It should not exceed 320 mcg two times a day. It should not surpass 320 mcg two times a day
Age 4-11 years
For both with earlier record/without earlier record of the inhaled corticosteroid usage: 40 mcg of beclomethasone inhaled orally two times a day; may enhance the dose for desired response following more than two weeks of treatment. It should not surpass 80 mcg two times a day
Age <4 years
Safety and efficacy not established
Future Trends
References
ADVERTISEMENT
Mild/moderate/severe:
875
mg
every 12 hrs or 500mg every 8hrs
In the case of mild/moderate infections: 500 mg orally every 12 hours or 400 mg intravenously every 12 hours for 7-14 days
In the case of severe/complicated infections: 750 mg orally every 12 hours or 400 mg intravenously every 8 hours for 7-14 days
Limitations for usage: Reserve the fluoroquinolones for patients who are voided of available treatment options for chronic bronchitis
Indicated for Chronic Asthma
For no earlier record of the inhaled corticosteroid usage: 40-80 mcg of beclomethasone inhaled orally two times a day as an initial dose may enhance the dose as necessary. It should not surpass 320 mcg two times a day
For an earlier record of the inhaled corticosteroid usage: 40-160 mcg of beclomethasone inhaled orally two times a day depending on earlier dose and disease severity. It should not surpass 320 mcg two times a day
Mild/moderate/severe :
45 mg/kg daily divided in doses for every 12hrs or 40 mg/kg per day in divided doses for every 8hrs
Indicated for Chronic Asthma
Age >12 years
For no earlier record of the inhaled corticosteroid usage: 40-80 mcg of beclomethasone inhaled orally two times a day; may enhance the dose for desired response following more than two weeks of treatment. It should not surpass 320 mcg two times a day
For earlier records of the inhaled corticosteroid usage: 40-160 mcg of beclomethasone inhaled orally two times a day depending on earlier dose and disease severity; may enhance the dose for desired response following more than two weeks of treatment. It should not exceed 320 mcg two times a day. It should not surpass 320 mcg two times a day
Age 4-11 years
For both with earlier record/without earlier record of the inhaled corticosteroid usage: 40 mcg of beclomethasone inhaled orally two times a day; may enhance the dose for desired response following more than two weeks of treatment. It should not surpass 80 mcg two times a day
Age <4 years
Safety and efficacy not established
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.